These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22710939)

  • 1. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.
    Abada PB; Larson CA; Manorek G; Adams P; Howell SB
    Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
    Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.
    Samimi G; Katano K; Holzer AK; Safaei R; Howell SB
    Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of copper transporters in resistance to platinating agents.
    Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.
    Li T; Peng J; Zeng F; Zhang K; Liu J; Li X; Ouyang Q; Wang G; Wang L; Liu Z; Liu Y
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):774-780. PubMed ID: 28737129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
    Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R
    Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).
    Li ZH; Qiu MZ; Zeng ZL; Luo HY; Wu WJ; Wang F; Wang ZQ; Zhang DS; Li YH; Xu RH
    J Transl Med; 2012 Feb; 10():21. PubMed ID: 22304828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
    BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.
    Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Inesi G; Galliani A; Sinisi M; Losacco M; Natile G; Arnesano F
    Angew Chem Int Ed Engl; 2014 Jan; 53(5):1297-301. PubMed ID: 24375922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
    Ip V; Liu JJ; Mercer JF; McKeage MJ
    Mol Pain; 2010 Sep; 6():53. PubMed ID: 20836889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
    Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
    Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.
    Katano K; Kondo A; Safaei R; Holzer A; Samimi G; Mishima M; Kuo YM; Rochdi M; Howell SB
    Cancer Res; 2002 Nov; 62(22):6559-65. PubMed ID: 12438251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
    Matsuzaki S; Enomoto T; Serada S; Yoshino K; Nagamori S; Morimoto A; Yokoyama T; Kim A; Kimura T; Ueda Y; Fujita M; Fujimoto M; Kanai Y; Kimura T; Naka T
    Int J Cancer; 2014 Apr; 134(8):1796-809. PubMed ID: 24150977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
    Song L; Li Y; Li W; Wu S; Li Z
    J Cell Biochem; 2014 Jul; 115(7):1234-42. PubMed ID: 24038379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of copper transporters in cisplatin resistance.
    Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
    Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.